Anti-tumor necrosis factor therapy does not diminish the immune response to influenza vaccine in Japanese patients with rheumatoid arthritis

Mod Rheumatol. 2007;17(6):531-3. doi: 10.1007/s10165-007-0632-5. Epub 2007 Dec 20.

Authors

Tetsuo Kubota¹, Tokiko Nii, Toshihiro Nanki, Hitoshi Kohsaka, Masayoshi Harigai, Yukiko Komano, Takahiko Sugihara, Yoshinori Nonomura, Wataru Hirose, Kenji Nagasaka, Tetsushi Sakurai, Nobuyuki Miyasaka

Affiliation

¹ Tokyo Medical and Dental University Graduate School of Health Sciences, 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8519, Japan. tetsuo.kubota.mtec@tmd.ac.jp

PMID: 18084712
DOI: 10.1007/s10165-007-0632-5

No abstract available

MeSH terms

Antibodies, Monoclonal / therapeutic use
Antibody Formation / immunology*
Antirheumatic Agents / immunology*
Antirheumatic Agents / therapeutic use
Arthritis, Rheumatoid / drug therapy
Arthritis, Rheumatoid / immunology*
Etanercept
Humans
Immunocompetence / drug effects
Immunocompetence / immunology*
Immunoglobulin G / therapeutic use
Infliximab
Influenza Vaccines / immunology*
Receptors, Tumor Necrosis Factor / therapeutic use
Tumor Necrosis Factor-alpha / antagonists & inhibitors*

Substances

Antibodies, Monoclonal
Antirheumatic Agents
Immunoglobulin G
Influenza Vaccines
Receptors, Tumor Necrosis Factor
Tumor Necrosis Factor-alpha
Infliximab
Etanercept